Keep up-to-date on the latest news at Acanthus Research including scientific events, global conferences, new products, and other company related news. You can also subscribe to our newsletter for ARI updates delivered right to your inbox!
March 26, 2020
ACANTHUS RESEARCH INC remains open As we address a pandemic that will no doubt become a chapter in the history books, our commitment to you will not waver. Of course,... Read More
October 30, 2019
Acanthus Research Inc. (ARI) is a leading Canadian company developing and manufacturing pharmaceutical reference standards. Our team of experienced scientists is adding new products to our portfolio every day, every... Read More
October 15, 2019
If you are interested in preparation and characterization of pharmaceutical reference standards, join us at CVG* 2019 Evening Seminar hosted by Covar Pharmaceuticals Inc. on Oct. 17. John Tobin, Director... Read More
June 12, 2019
Below are the highlights of products added in May 2019. All products are fully certified with detailed certificates of analysis. Ecopipam-13C6 (racemic) as HCl; Catalogue No. E-90426-01 Ecopipam Desmethyl 13C6 (racemic)... Read More
March 21, 2019
Acanthus Research Inc. (ARI) is a leading Canadian company developing and manufacturing pharmaceutical reference standards. Our team of experienced scientists is adding new products to our portfolio every day, every... Read More
January 25, 2019
Acanthus Research Inc. now offers a large collection of clindamycin-related analytical reference standards. All standards are of high purity and are accompanied by Certificate of Analysis. Clindamycin (Cleocin HCl, Dalacin,... Read More
February 10, 2015
Acanthus Research Inc. has expanded its offering of Calcipotriol EP Impurities (A, C, D, F and I). Click here to view the structures. Each impurity standard is accompanied with a Certificate of... Read More
February 2, 2015
Acanthus Research Inc. now offers a large collection of clindamycin-related analytical reference standards. All standards are of high purity and are accompanied by Certificate of Analysis. To request the CofA... Read More
February 2, 2015
Analytical reference standards of three potentially genotoxic impurities of nilotinib (Tasigna) are now available from Acanthus Research: Nilotinib Genotoxic Impurity 1 (CAS No. 641571-11-1), Nilotinib Genotoxic Impurity 2 (CAS No.1157857-29-8), and... Read More
February 1, 2015
Analytical reference standards of two potentially genotoxic impurities of lapatinib (Tykerb, Tyverb) are now available from Acanthus Research Inc.: Lapatinib Genotoxic Impurity 1 (CAS No. 202197-26-0) and Lapatinib Genotoxic Impurity 2 (CAS... Read More